INTRODUCTION
Benzophenone is used in medicines, UV stabilizers, aroma retention reagents and others, and also found in waste water. It is listed among "the chemicals suspected of having endocrine disrupting effects," 1) however, it has been reported to have no estrogenic activity. [2] [3] [4] [5] [6] In contrast, several hydroxylated benzophenones had a higher estrogenic activity in a variety of assays. These assays included the MCF-7 cell assay, 2, 3) the competitive binding assay, 4, 5) the reporter gene assay [6] [7] [8] and the uterotrophic assay. 5, 8, 9) One derivative, 2-hydroxy-4-methoxybenzophenone was also reported to be an androgenic antagonist. 10) Hydroxylated benzophenones are used as UV-stabilizers in a variety of commercial products, such as sunscreens, cosmetics, and plastics. Some are also produced in the body as the metabolites of benzophenone and its derivatives. 2, 3, 11, 12) In the previous paper, 13) we tested the estrogenic activities of benzophenone and 19 hydroxylated benzophenones using the yeast two-hybrid assay. Among them, fifteen expressed estrogenic activity, some showed a higher activity than bisphenol A, and the results provided an indication of the structure-activity relationships. While the results raised questions concerning the ability of the yeast two-hybrid assay to predict the results in living animals.
A number of in vitro mammalian cell-based assays have been developed to evaluate endocrine disruption, and recently the genetically engineered mammalian stable cell lines, the so-called ER- The estrogenic and anti-androgenic activities of benzophenone and 19 hydroxylated derivatives were measured in reporter gene assays using transfected human estrogen and androgen receptors in Chinese hamster ovary cells. Eighteen benzophenones had estrogenic activity and seventeen also had anti-androgenic activity. In both assays, 2,4,4′-trihydroxybenzophenone and 2,2′,4,4′-tetrahydroxybenzophenone showed the strongest activity which were comparable to bisphenol A or 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE). The structure-activity relationships of the estrogenic activity in this mammalian reporter gene assay were mostly similar to the yeast two-hybrid assay as previously reported. Benzophenones hydroxylated at the 3 or 4-position showed the estrogenic activity, while the others showed negative or weakly positive activities. Moreover, a hydroxyl group added at the 2-position of the 4-hydroxylated benzophenone enhanced activity, but reduced activity at the 3-position. In contrast, different results were obtained when a hydroxyl group was added to another benzene ring. The added hydroxyl group enhanced the activity in this reporter gene assay, but reduced it in the yeast two-hybrid assay. Results from the reporter gene assay corresponded with the in vivo uterotrophic assay. On the other hand, a hydroxyl group at the 2-position generally enhanced the anti-androgenic activity, though the effect of other hydroxyl groups was less clear. Meanwhile, these benzophenones had no or very weak androgen agonistic activities.
Estrogenic and Anti-Androgenic Activities of Benzophenones in Human Estrogen
EcoScreen™ and AR-EcoScreen™, have been developed as a sensitive and rapid method to screen hormonally active chemicals. [14] [15] [16] [17] They can detect the transcriptional activities mediated with the human estrogen receptor α (hERα) or androgen receptor (hAR). In this study, we investigated the estrogenic and anti-androgenic activities of benzophenone and 19 hydroxylated benzophenones using these cell lines.
MATERIALS AND METHODS
Reagents ---17β-Estradiol (E 2 ), bisphenol A (BPA), 5α-dihydrotestosterone (DHT), 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE), cycloheximide and benzophenone were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Hydroxyflutamide was purchased from Tronto Research Chemicals, Inc. (NY, U.S.A.), 3-hydroxybenzophenone was purchased from Sigma-Aldrich Japan Co. (Tokyo, Japan), and the other benzophenone derivatives and 4-nonylphenol (NP) were purchased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). The benzophenones tested in this study are listed in Table 1 and their structures were shown in the previous paper.
13)
Cell Culture ---The ERα-EcoScreen™ and AREcoScreen™ cells (Otsuka Pharmaceutical, Tokyo, Japan) were derived from the Chinese hamster ovary cell line (CHO-K1, American Type Culture Collection) that was stably transfected with the expression vectors pcDNAERα or pZeoSV2AR containing the cDNA of hERα or hAR, respectively. [14] [15] [16] [17] To evaluate the cell viability from test chemicals, the cLucEcoScreen™ cell was stably transfected luciferase gene (pcDNA-luc) into CHO-K1 cells, which constitutively expressed luciferase without any induction. 16, 17) They are cultured in assay medium composed of D-MEM/F12 (Invitrogen, CA, U.S.A.) without phenol red, and supplemented with 5% charcoaldextran treated FBS (Hyclone, UT, U.S.A.). The cells were grown at 37°C in an atmosphere containing 5% CO 2 /95% air under saturating humidity and passaged every 3-4 days by trypsinization with 0.25% 
trypsin/0.02% ethylenediamine tetraacetic acid (EDTA) disodium salt solution. hER␣ Mediated Reporter Gene Agonist Assay Procedure ---The stock solutions of the test chemicals (10 -1 M in dimethyl sulfoxide, DMSO) were 10 times serially diluted with DMSO to provide 7 concentrations in the range of 10 -1 to 10 -7 M. This DMSO solutions were further diluted with D-MEM/F-12 with no supplement, so that the final DMSO concentration was 0.1% (v/v). The ERα-EcoScreen™ cells were suspended at a density of 1 × 10 5 /ml in assay medium, and seeded with 90 µl in 96-well plates. After a 24-hr culture, 10 µl of the prepared sample solution was added to the plates and cultured for 16-24 hr. The final concentrations of test samples applied to the cells ranged from 10 -4 to 10 -10 M. The solvent control and 10 -9 M E 2 , which served as the positive control, were incubated in each plate. Following the 24-hr culture, the luciferase substrate, Steady-Glo™ (Promega, WI, U.S.A.) was added to all the assay wells. After shaking at room temperature for 5 min, the chemiluminescence was measured using a Wallac 1420 ARVO SX multi-label counter (Perkin-Elmer, MA, U.S.A.). hAR Mediated Reporter Gene Agonist Assay Procedure ---The AR-EcoScreen™ cells were prepared with same procedure as the hERα mediated reporter gene agonist assay using 10 -8 M DHT in stead of 10 -9 M E 2 as the positive control. hAR Mediated Reporter Gene Antagonist Assay Procedure ---The AR-EcoScreen™ cells and cLuc-EcoScreen™ cells were prepared with same procedure as the hERα mediated reporter gene agonist assay with the following exceptions. D-MEM/ F-12 containing 5 × 10 -10 M of DHT was used for the final sample diluent. This concentration of DHT was about 70% of the plateau level.
The prepared samples were added to the 96-well plates separately seeded with AR-EcoScreen™ or cLuc-EcoScreen™. The positive control (10 -8 M DHT), solvent control and 1 µg/ml cycloheximide as cell toxicity positive control were included in each plate. Data and Statistical Analysis ---Data were presented as the mean and S.D. of at least triplicate assays. Dose-response data were fitted using the 
RESULTS

Estrogenic Activity of Benzophenones in the hER␣ Mediated Reporter Gene Agonist Assay
The estrogenic activity of E 2 , BPA, NP and the benzophenones, as measured by the dose response curves (Fig. 1) and corresponding EC 50 and PC 50 values (Table 1) were determined using ERα-EcoScreen™.
The estrogenic activity of E 2 was detectable at levels greater than 10 -12 M. The maximum induction was about 6-fold greater than the control at concentrations over 10 -10 M. BPA and NP, which are well-known endocrine disrupting chemicals, showed approximately 1/10000 and 1/20000 of the E 2 activity, respectively.
The eighteen benzophenones showed estrogenic activities between 10 -8 and 10 -4 M. Among of them, eight hydroxylated benzophenones, such as 3-hydroxybenzophenone, 2,4,4′-trihydroxybenzophenone, 2,2′,4,4′-tetrahydroxybenzophenone and 4-hydroxy-4′-chlorobenzophenone, elicited luciferase induction much higher than E 2 , which is referred to as super-agonism.
19) The mechanism of this phenomenon is not clear, but it may be due to the stimulated receptor and/or co-activation factor renewal by the pseudo-estrogens or the increased stability of luciferase. Due to the super-agonism, these chemicals were shown high EC 50 values, though their induction was detectable at low concentrations. Therefore, the PC 50 values were used for evaluating the estrogenic activity in substitution for the EC 50 values.
The PC 50 values of 2,4,4′-trihydroxybenzophenone and 2,2′,4,4′-tetrahydroxybenzophenone were about 10 -7 M, which were comparable to BPA and NP. Benzophenone, 2,2′-dihydroxybenzophenone and 2,2′-dihydroxy-4-methoxybenzophenone showed weak estrogenic activities at 10 -4 M. Only two benzophenones, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and 2-hydroxy-4-n-octyloxybenzophenone displayed no activity.
Androgenic Activity of Benzophenones in the hAR Mediated Reporter Gene Agonist Assay
The AR agonist activities of the benzophenones were examined (Table 2) . Four chemcals, 4,4′-trihydroxybenzophenone, 2,2′,4,4′-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone and 2,2′-dihydroxy-4,4′-dimethoxybenzophenone, showed a 1.7-2.0 fold weak induction in AR activity only at 10 -4 M. By this means, all of the benzophenones could not be detected their EC 50 values. In other words, they had no or very weak androgenic activity.
Anti-Androgenic Activity of Benzophenones in the hAR Mediated Reporter Gene Antagonist Assay
The anti-androgenic activities of hydroxyflutamide, DDE and the benzophenones were determined using the AR-EcoScreen™ in the presence of 5 × 10 -10 M DHT. In addition, the cell toxicity was measured using the cLuc-EcoScreen™. The anti-androgenic activity (IC 50 ) and the cell viability are shown in Table 2 , and the dose-response inhibitory curves of typical chemicals are shown in Fig. 2 .
The anti-androgenic activity of hydroxy- Table 1 . Values are presented as fold induction compared to vehicle controls and represent the mean ± S.D. of triplicate assays. The dashed line shows 50% activity of 10 -9 M E 2 (PC 50 ).
flutamide and DDE, which are known anti-androgenic compounds, became detectable at levels greater than 10 -8 and 10 -7 M, and their IC 50 values were 1.0 × 10 -7 and 2.3 × 10 -6 M, respectively. Seventeen benzophenones had anti-androgenic activities between 10 -4 and 10 -7 M. The activity of 2,4,4′-trihydroxybenzophenone and 2,2′,4,4′-tetrahydroxybenzophenone were expressed at levels greater than 10 -7 M. The corresponding IC 50 values were 1.9 × 10 -6 and 2.5 × 10 -6 M, respectively. Their potencies were similar to DDE. Benzophenone showed activity only at 10 -4 M, and its IC 50 was 7.7 × 10 -5 M. While, three hydroxylated benzophenones, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and 2-hydroxy-4-n-octyloxybenzophenone did not show anti-androgenic activities.
Some benzophenones produced cytotoxicity. For example, 2,3′,4,4′-tetrahydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone and 4-hydroxy-4′-chlorobenzophenone killed about 60% of the cells at 10 -4 M. However, all of the cell viabilities at the concentration of their IC 50 were over 96%. Therefore, it was evaluated that the cytotoxicity did not affect the IC 50 values of these benzophenones.
DISCUSSION
This hERα mediated reporter gene assay showed a higher sensitivity for the detecting estrogenic activity of the benzophenones than the other in vitro assays, such as the MCF-7 cell assay, 2,3) the competitive binding assay 4, 5) and the recombinant yeast assay. 6) Compared with our previous results using the yeast two-hybrid assay, 13) this assay detected the activity of 18 benzophenones, while the yeast twohybrid assay detected the activity in 15 benzophenones. These three benzophenones including benzophenone could not detected 10% relative effective concentration (REC 10 ) in the yeast two-hybrid assay though they showed weak induction, and this reporter gene assay could detect their activities because of its sensitivity. The other 15 positive compounds were in common with both assays, and the estrogenic activities tested by this method (PC 50 ) and the yeast two-hybrid assay (REC 10 ) were correlated (r = 0.79).
Both assays showed a similar structure-activity relationship as follows. Benzophenones hydroxylated at the 3 or 4 position had more estrogenic activity, while the benzophenones without them had no or lower activity. Furthermore, when a hydroxyl group was added to the 2-position in the 4-hydroxylated benzophenones, the activity was enhanced, for instance, 4-hydroxybenzophenone < 2,4-dihydroxybenzophenone, and 4,4′-dihydroxybenzophenone < 2,4,4′-trihydroxybenzophenone. We hypothesized that the 2-hydroxyl group interacted with the carbonyl group, the benzophenone structure became fixed, and the molecule fit the hERα receptor. However, a hydroxyl group added to the 3-position in 4-hydroxylated benzophenones reduced the activity in the order 2,4-dihydroxybenzophenone > 2,3,4-trihydroxybenzophenone, and 2,4,4′-trihydroxybenzophenone > 2,3,4,4′-tetrahydroxybenzophenone. The 3-hydroxyl group probably interfered with the role of the 4-hydroxyl group.
However, different results were obtained when a hydroxyl group was added to anather benzene ring. The added hydroxyl group enhanced the activity in this reporter gene assay, for instance, 4-hydroxybenzophenone < 4,4′-dihydroxybenzophenone, 2,4-dihydroxybenzophenone < 2,4,4′-trihydroxybenzophenone, and 2,3,4-trihydroxybenzophenone < 2,3,4,4′-tetrahydroxybenzophenone, but it reduced the activity in the yeast two-hybrid assay.
The in vivo uterotrophic assay of benzophenones were reported by Nakagawa, 5) Yamazaki 8) and Koda 20) (Table 3 ). They showed a good correlation with their PC 50 values in this reporter gene assay. The reporter gene assay provided results more similar to the in vivo uterotrophic assay than the yeast two-hybrid assay did. This was provably caused by the steric exclusion of the coactivator situated next to the estrogen receptor in the yeast two-hybrid assay.
An anti-androgenic activity was displayed by 17 benzophenones. All of them also showed an estrogenic activity, and 2,4,4′-trihydroxybenzophenone and 2,2′,4,4′-tetrahydroxybenzophenone expressed the strongest activities for both the estrogenic and anti-androgenic activities. The hydroxyl group in 2-position of benzophenones had a tendency to enhance this activity. However, the effect of the hydroxyl group in other positions on the anti-androgenic activities was less clear than that on the estrogenic activities. Since the correlation between the estrogenic and anti-androgenic activities was 0.68, the hydroxylated benzophenones could easily bind with both receptors.
In contrast, these benzophenones showed no or very weak androgenic activities. Yamazaki 8) reported the Hershberger assay of 4,4′-dihydroxybenzophenone, 2,2′,4,4′-tetrahydroxybenzophenone, 4-hydroxybenzophenone and 2,4,4′-trihydroxybenzophenone, in which they did not show the androgen agonistic effect.
In fact, the most of hydroxylated benzophenones could easily bound with the estrogen and androgen receptors. When the molecule was bound to the receptors, the receptor-molecule complex would initiate an estrogenic activity in estrogen receptor, though they inhibit the androgen-like molecules from initiating the androgen activity in androgen receptor. In other words, hydroxylated benzophenones would act as endocrine disrupters based on both their estrogenic activity and anti-androgenic activities.
This investigation revealed that hydroxylated benzophenones possessed both estrogenic activity and anti-androgenic activities at high frequency. These chemicals are used in commercial products such as UV stabilizers in plastics, sunscreens, and cosmetics. In addition, they are also produced in the body as metabolites of benzophenone and its derivatives. Because of their wide exposure and ability to disrupt endocrine activity, more work is needed to evaluate the potential health effects of hydroxylated benzophenones. 
